These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(MARK ONE)
|
|
|
x
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
For the fiscal year ended December 31, 2013
|
|
|
OR
|
|
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
For the transition period from ___________ to ___________
|
|
|
Nevada
|
22-3962936
|
|
(State or other jurisdiction of incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
|
9436 Jacob Lane, Rosemead, CA 91770
|
91770
|
|
(Address of principal executive offices)
|
(Zip Code)
|
|
Large accelerated filer
o
|
Accelerated filer
o
|
Non-accelerated filer
o
|
Smaller reporting company
x
|
|
PART I
|
|||
|
Item 1
|
4
|
||
|
Item 1A
|
5
|
||
|
Item 2
|
8
|
||
|
Item 3
|
8
|
||
|
Item 4
|
8
|
||
|
PART II
|
|||
|
Item 5
|
9
|
||
|
Item 6
|
9
|
||
|
Item 7
|
12
|
||
|
Item 8
|
12
|
||
|
Item 8A
|
12
|
||
|
Item 8B
|
13
|
||
|
PART III
|
|||
|
Item 9
|
14
|
||
|
Item 10
|
15
|
||
|
Item 11
|
15
|
||
|
Item 12
|
15
|
||
|
Item 13
|
15
|
||
|
PART IV
|
|||
|
Item 14
|
16
|
||
|
18
|
|||
|
NAME
|
AGE
|
POSITIONS HELD WITH COMPANY
|
||
|
Frank S. Yuan
|
65 |
Chairman and Chief Executive Officer since 2007
|
||
|
Charles Rice
|
71 |
Director since 2007
|
||
|
James Vandeberg
|
69 |
Director since 2007
|
||
|
Peter Lin
|
44 |
Director since 2010
|
||
|
Deborah Shamaley
|
55 |
Director since 2007
|
|
Long Term Compensation
|
||||||||||||||||||||||||||||||
|
Annual Compensation
|
Awards
|
Payouts
|
||||||||||||||||||||||||||||
|
Name and
Principal Position
|
Year
|
Salary ($)
|
Bonus ($)
|
Other Annual Compensation
|
Restricted Stock Award(s)
|
Securities Underlying Options/SARs (#)
|
LTIP Payouts ($)
|
All Other Compensation
|
||||||||||||||||||||||
|
Yuan, Frank
|
2013
|
$
|
-
|
$
|
-
|
$
|
-
|
$
|
-
|
N/A
|
$
|
-
|
$
|
-
|
||||||||||||||||
|
(CEO)
|
2012
|
$
|
-
|
$
|
-
|
$
|
-
|
$
|
-
|
N/A
|
$
|
-
|
$
|
-
|
||||||||||||||||
|
Type of Services Rendered
|
2013
|
2012
|
||||||
|
Audit Fees
|
$
|
5,000
|
$
|
3,000
|
||||
|
Audit-Related Fees
|
$
|
1,950
|
$
|
-
|
||||
|
Tax Fees
|
$
|
-
|
$
|
-
|
||||
|
All Other Fees
|
$
|
-
|
$
|
-
|
||||
|
F-1
|
|
|
Financial Statements
|
|
|
F-2
|
|
|
F-3
|
|
|
F-4
|
|
| Statements of Cash Flows for the years ended December 31, 2013 and 2012 |
F-5
|
|
F-6
|
|
December 31,
|
December 31,
|
|||||||
|
2013
|
2012
|
|||||||
|
ASSETS
|
||||||||
|
Current Assets
|
||||||||
|
Cash
|
$ | 205,967 | $ | 8,752 | ||||
|
Prepaid income taxes
|
800 | 800 | ||||||
|
Due from affiliated company
|
9,527 | 52,298 | ||||||
|
Total Current Assets
|
216,294 | 61,850 | ||||||
|
Equipment, net
|
21,665 | - | ||||||
|
Total Assets
|
$ | 237,959 | $ | 61,850 | ||||
|
LIABILITIES AND STOCKHOLDERS' DEFICIT
|
||||||||
|
Current Liabilities
|
||||||||
|
Accounts payable and accrued expenses
|
$ | 262,192 | $ | 203,563 | ||||
|
Auto Loan, current
|
4,905 | - | ||||||
|
Due to affiliated company
|
245,740 | 1,511 | ||||||
|
Total Current Liabilities
|
512,837 | 205,074 | ||||||
|
Long-term Liabilities
|
||||||||
|
Auto Loan, noncurrent
|
17,169 | - | ||||||
|
Convertible note, officers
|
676,505 | 1,599,418 | ||||||
|
Total Long-term Liabilities
|
693,674 | 1,599,418 | ||||||
|
Total Liabilities
|
1,206,511 | 1,804,492 | ||||||
|
Stockholders' Deficit
|
||||||||
|
Common stock, $.001 par value, 45,000,000 shares authorized,
14,445,363 and 8,701,363 shares issued and outstanding at December 31, 2013 and December 31, 2012
|
14,445 | 8,705 | ||||||
|
Additional paid in capital
|
(902,272 | ) | (1,126,292 | ) | ||||
|
Accumulated deficit
|
(80,725 | ) | (625,055 | ) | ||||
|
Total Stockholders' Deficit
|
(968,552 | ) | (1,742,642 | ) | ||||
|
Total Liabilities and Stockholders' Deficit
|
$ | 237,959 | $ | 61,850 | ||||
|
Year Ended December 31,
|
||||||||
|
2013
|
2012
|
|||||||
|
Revenues:
|
||||||||
|
Commission income
|
$ | 967 | $ | 9,124 | ||||
|
Consulting fee
|
1,704,962 | 483,775 | ||||||
|
Management Fee
|
15,000 | - | ||||||
|
Total revenues
|
1,720,929 | 492,899 | ||||||
|
Cost of Sales
|
||||||||
|
Consulting expense
|
653,800 | 261,852 | ||||||
|
Gross Profit
|
1,067,129 | 231,047 | ||||||
|
General and administrative
|
452,327 | 75,946 | ||||||
|
Income from operations
|
614,802 | 155,101 | ||||||
|
Other Expense
|
||||||||
|
Interest expense
|
(70,472 | ) | (100,320 | ) | ||||
|
Total other (Expense)
|
(70,472 | ) | (100,320 | ) | ||||
|
Income before income taxes
|
544,330 | 54,781 | ||||||
|
Income taxes
|
- | - | ||||||
|
Net Income and comprehensive income
|
$ | 544,330 | $ | 54,781 | ||||
|
Net income per common share
|
||||||||
|
Basic and diluted
|
$ | 0.05 | $ | 0.01 | ||||
|
Diluted
|
$ | 0.02 | $ | 0.01 | ||||
|
Weighted average common shares outstanding
|
||||||||
|
Basic
|
11,156,333 | 8,704,669 | ||||||
|
Diluted
|
27,849,432 | 8,704,669 | ||||||
|
Additional
|
Total
|
|||||||||||||||||||
|
Common stock
|
paid in
|
(Accumulated
|
stockholders'
|
|||||||||||||||||
|
Shares
|
Amount
|
capital
|
deficit)
|
deficit
|
||||||||||||||||
|
Balance , January 1, 2012
|
8,701,363 | $ | 8,705 | $ | (1,126,292 | ) | $ | (679,836 | ) | $ | (1,797,423 | ) | ||||||||
|
Net income
|
- | - | - | 54,781 | 54,781 | |||||||||||||||
|
Balance , December 31, 2012
|
8,701,363 | 8,705 | (1,126,292 | ) | (625,055 | ) | (1,742,642 | ) | ||||||||||||
|
Conversion of convertible note and accrued interest to common stock
|
5,744,000 | 5,744 | 224,016 | - | 229,760 | |||||||||||||||
|
Adjust prior period cancelled common stock
|
- | (4 | ) | 4 | - | - | ||||||||||||||
|
Net income
|
- | - | - | 544,330 | 544,330 | |||||||||||||||
|
Balance , December 31 2013
|
14,445,363 | $ | 14,445 | $ | (902,272 | ) | $ | (80,725 | ) | $ | (968,552 | ) | ||||||||
|
Year Ended December 31,
|
||||||||
|
2013
|
2012
|
|||||||
|
Operating Activities:
|
||||||||
|
Net Income
|
$ | 544,330 | $ | 54,781 | ||||
|
Adjustments to reconcile net income to net cash
provided by operating activities:
|
||||||||
|
Depreciation expense
|
2,861 | - | ||||||
|
Interest Expenses
|
29,760 | |||||||
|
Changes in operating assets and liabilities:
|
||||||||
|
Prepaid expenses and other receivables
|
- | 175,000 | ||||||
|
Accounts payable and accrued expenses
|
58,628 | 101,845 | ||||||
|
Net cash provided by operating activities
|
635,579 | 331,626 | ||||||
|
Investing Activities:
|
||||||||
|
Payment from affiliated company
|
42,773 | - | ||||||
|
Net cash used in investing activities
|
42,773 | - | ||||||
|
Financing Activities:
|
||||||||
|
Payments on auto loan
|
(2,453 | ) | - | |||||
|
Advance from (Repayment to) affiliated company
|
244,229 | (50,278 | ) | |||||
|
Proceeds from borrowings on convertible note from officers
|
309,570 | 521,648 | ||||||
|
Repayments of borrowings on convertible note from officers
|
(1,032,483 | ) | (799,524 | ) | ||||
|
Net cash used in financing activities
|
(481,137 | ) | (328,154 | ) | ||||
|
Net increase in cash
|
197,215 | 3,472 | ||||||
|
Cash, beginning of period
|
8,752 | 5,280 | ||||||
|
Cash, end of period
|
$ | 205,967 | $ | 8,752 | ||||
|
Supplemental disclosures of cash flow information:
|
||||||||
|
Cash paid during the period
|
||||||||
|
Interest
|
$ | - | $ | 8 | ||||
|
Income taxes
|
$ | - | $ | - | ||||
|
Non-cash investing and financing activities:
|
||||||||
|
Vehicle purchased through auto loan
|
$ | 24,527 | $ | - | ||||
|
Conversion of convertible note to common stock
|
$ | 200,000 | $ | - | ||||
|
December 31,
|
December 31,
|
|||||||
|
2013
|
2012
|
|||||||
|
Automobile
|
$
|
24,526
|
$
|
-
|
||||
|
24,526
|
-
|
|||||||
|
Less: Accumulated depreciation
|
(2,861
|
)
|
-
|
|||||
|
$
|
21,665
|
$
|
-
|
|||||
|
For the Year Ended December 31:
|
||||
|
2014
|
4,905
|
|||
|
2015
|
4,905
|
|||
|
2016
|
4,905
|
|||
|
2017
|
4,905
|
|||
|
2018
|
2,454
|
|||
|
22,074
|
||||
|
Less Current Portion
|
(4,905
|
)
|
||
|
Long Term Portion
|
$
|
17,169
|
||
|
Year Ended December 31,
|
||||||||
|
2013
|
2012
|
|||||||
|
Net operating loss
|
$
|
(185,072
|
)
|
$
|
(18,626
|
)
|
||
|
Total deferred tax assets
|
(185,072
|
)
|
(18,626
|
)
|
||||
|
Reversal of valuation allowance
|
185,072
|
18,626
|
||||||
|
Net deferred tax assets
|
$
|
-
|
$
|
-
|
||||
|
Exhibit No.
|
Description
|
Location
|
|
31.1
|
Filed herewith.
|
|
|
32.1
|
Filed herewith.
|
|
|
101.INS
|
XBRL Instance Document
|
Furnished electronically with this filing
|
|
101.SCH
|
XBRL Taxonomy Extension Schema Document
|
Furnished electronically with this filing
|
|
101.CAL
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
Furnished electronically with this filing
|
|
101.DEF
|
XBRL Taxonomy Extension Definition Linkbase Document
|
Furnished electronically with this filing
|
|
101.LAB
|
XBRL Taxonomy Extension Label Linkbase Document
|
Furnished electronically with this filing
|
|
101.PRE
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
ASAP EXPO, INC.
|
|||
|
Date: April 15, 2014
|
By:
|
/s/ Frank Yuan
|
|
|
Frank Yuan
|
|||
|
Chief Executive Officer and President
|
|||
|
By:
|
/s/ Frank S. Yuan
|
Date: April 15, 2014
|
|
|
Frank S. Yuan
|
|||
|
Director
|
|||
|
By:
|
/s/ Charles Rice
|
Date: April 15, 2014
|
|
|
Charles Rice
|
|||
|
Director
|
|||
|
By:
|
/s/ Deborah Shamaley
|
Date: April 15, 2014
|
|
|
Deborah Shamaley
|
|||
|
Director
|
|||
|
By:
|
/s/ James Vandeberg
|
Date: April 15, 2014
|
|
|
James Vandeberg
|
|||
|
Director
|
|||
|
By:
|
/s/ Peter Lin
|
Date: April 15, 2014
|
|
|
Peter Lin
|
|||
|
Director
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|